Am. J. Respir. Crit. Care Med., Volume 160, Number 5, November 1999, 1486-1492

Eosinophilic Inflammation in Stable Chronic Obstructive Pulmonary Disease
Relationship with Neutrophils and Airway Function

GIOVANNI BALZANO, FRANCESCO STEFANELLI, CARMELA IORIO, ALBERTO DE FELICE, ENRICO M. MELILLO, MICHELE MARTUCCI, and GAETANO MELILLO

Division of Pneumology, Rehabilitation Institute of Telese Terme, Salvatore Maugeri Foundation, Telese Terme, Benevento, Italy

The number and significance of airway eosinophils in stable COPD is controversial. Aims of this study were to evaluate airway inflammation in patients with stable COPD compared with other groups, and to examine the correlations between inflammatory markers and functional indices of airway obstruction. Cellular analysis and evaluation of eosinophil cationic protein (ECP) levels in induced sputum were made in 46 subjects (10 patients with clinically stable COPD, 15 patients with asthma, 11 asymptomatic smokers, and 10 healthy control subjects). As expected, eosinophils were significantly (p < 0.01) higher in patients with asthma (22.2%) than in other groups (COPD, 0.7%; smokers, 0.2%; control subjects, 0.2%), and neutrophils were significantly (p < 0.01) higher in patients with COPD (77.5%) than in the other groups (asthma, 26.7%; smokers, 33.1%; control subjects, 35.9%). However, eosinophils were also increased in patients with COPD, as compared with healthy controls (p < 0.05). Sputum ECP levels were significantly and similarly higher in both asthma and COPD groups than in the other two groups (p < 0.01). In patients with COPD and asymptomatic smokers, considered as a whole, good correlations were found between eosinophils and ECP, on the one hand, and between FEV₁ and the FEV₁/FVC ratio, on the other. Our data suggest that eosinophils may be involved in the airway inflammation of COPD. Balzano G, Stefanelli F, Iorio C, De Felice A, Melillo EM, Martucci M, Melillo G. Eosinophilic inflammation in stable chronic obstructive pulmonary disease: relationship with neutrophils and airway function.

This article has been cited by other articles:

				D-W. Perng, C-W. Tao, K-C. Su, C-C. Tsai, L-Y. Liu, and Y-C. Lee Anti-inflammatory effects of salmeterol/fluticasone, tiotropium/fluticasone or tiotropium in COPD Eur. Respir. J., April 1, 2009; 33(4): 778 - 784. [Abstract] [Full Text] [PDF]

				D Shaw Exhaled nitric oxide: time to employ or make redundant? Chronic Respiratory Disease, February 1, 2009; 6(1): 3 - 4. [PDF]

				C.-J. Li, W. Ning, M. A. Matthay, C. A. Feghali-Bostwick, and A. M. K. Choi MAPK pathway mediates EGR-1-HSP70-dependent cigarette smoke-induced chemokine production Am J Physiol Lung Cell Mol Physiol, May 1, 2007; 292(5): L1297 - L1303. [Abstract] [Full Text] [PDF]

				M.-C. L. Machado, J. A. Krishnan, S. A. Buist, A. L. Bilderback, G. P. Fazolo, M. G. Santarosa, F. Queiroga Jr., and W. M. Vollmer Sex Differences in Survival of Oxygen-dependent Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., September 1, 2006; 174(5): 524 - 529. [Abstract] [Full Text] [PDF]

				S. F. P. Man and D. D. Sin Effects of Corticosteroids on Systemic Inflammation in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, April 1, 2005; 2(1): 78 - 82. [Abstract] [Full Text] [PDF]

				A. Linden, M. Laan, and G. P. Anderson Neutrophils, interleukin-17A and lung disease Eur. Respir. J., January 1, 2005; 25(1): 159 - 172. [Abstract] [Full Text] [PDF]

				D. D. Sin, P. Lacy, E. York, and S. F. P. Man Effects of Fluticasone on Systemic Markers of Inflammation in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., October 1, 2004; 170(7): 760 - 765. [Abstract] [Full Text] [PDF]

				T. S. Lapperre, J. B. Snoeck-Stroband, M. M.E. Gosman, J. Stolk, J. K. Sont, D. F. Jansen, H. A.M. Kerstjens, D. S. Postma, and P. J. Sterk Dissociation of Lung Function and Airway Inflammation in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., September 1, 2004; 170(5): 499 - 504. [Abstract] [Full Text] [PDF]

				S.K. Jindal Dutch Hypothesis: Revisited? Chest, August 1, 2004; 126(2): 329 - 331. [Full Text] [PDF]

				D.-W. Perng, H.-Y. Huang, H.-M. Chen, Y.-C. Lee, and R.-P. Perng Characteristics of Airway Inflammation and Bronchodilator Reversibility in COPD: A Potential Guide to Treatment Chest, August 1, 2004; 126(2): 375 - 381. [Abstract] [Full Text] [PDF]

				C. Schulz, K. Kratzel, K. Wolf, S. Schroll, M. Kohler, and M. Pfeifer Activation of Bronchial Epithelial Cells in Smokers Without Airway Obstruction and Patients With COPD Chest, May 1, 2004; 125(5): 1706 - 1713. [Abstract] [Full Text] [PDF]

				P. Berger, F. Laurent, H. Begueret, V. Perot, R. Rouiller, C. Raherison, M. Molimard, R. Marthan, and J. M. Tunon-de-Lara Structure and Function of Small Airways in Smokers: Relationship between Air Trapping at CT and Airway Inflammation Radiology, July 1, 2003; 228(1): 85 - 94. [Abstract] [Full Text] [PDF]

				S. S. Birring, C. E. Brightling, P. Bradding, J. J. Entwisle, D. D. Vara, J. Grigg, A. J. Wardlaw, and I. D. Pavord Clinical, Radiologic, and Induced Sputum Features of Chronic Obstructive Pulmonary Disease in Nonsmokers: A Descriptive Study Am. J. Respir. Crit. Care Med., October 15, 2002; 166(8): 1078 - 1083. [Abstract] [Full Text] [PDF]

				R.E. Louis, D. Cataldo, M.G. Buckley, J. Sele, M. Henket, L.C. Lau, P. Bartsch, A.F. Walls, and R. Djukanovic Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease Eur. Respir. J., August 1, 2002; 20(2): 325 - 331. [Abstract] [Full Text] [PDF]

				M. Miravitlles Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? Eur. Respir. J., July 1, 2002; 20(36_suppl): 9S - 19s. [Abstract] [Full Text] [PDF]

				T. L. CROXTON, G. G. WEINMANN, R. M. SENIOR, and J. R. HOIDAL Future Research Directions in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., March 15, 2002; 165(6): 838 - 844. [Full Text] [PDF]

				P G Gibson, M Fujimura, and A Niimi Eosinophilic bronchitis: clinical manifestations and implications for treatment Thorax, February 1, 2002; 57(2): 178 - 182. [Abstract] [Full Text] [PDF]

				P. MAESTRELLI, M. SAETTA, C. E. MAPP, and L. M. FABBRI Remodeling in Response to Infection and Injury . Airway Inflammation and Hypersecretion of Mucus in Smoking Subjects with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): S76 - 80. [Abstract] [Full Text] [PDF]

				P MAESTRELLI, L RICHELDI, M MORETTI, and L M FABBRI Analysis of sputum in COPD Thorax, June 1, 2001; 56(6): 420 - 422. [Full Text]

				P. E. Silkoff, D. Martin, J. Pak, J. Y. Westcott, and R. J. Martin Exhaled Nitric Oxide Correlated With Induced Sputum Findings in COPD Chest, April 1, 2001; 119(4): 1049 - 1055. [Abstract] [Full Text] [PDF]

				M. Komori, H. Inoue, K. Matsumoto, H. Koto, S. Fukuyama, H. Aizawa, and N. Hara PAF mediates cigarette smoke-induced goblet cell metaplasia in guinea pig airways Am J Physiol Lung Cell Mol Physiol, March 1, 2001; 280(3): L436 - L441. [Abstract] [Full Text] [PDF]